Loading...

Eastgate Biotech Corp.

ETBIPNK
Healthcare
Medical - Pharmaceuticals
$0.004
$0.00(0.00%)

Eastgate Biotech Corp. (ETBI) Company Profile & Overview

Explore Eastgate Biotech Corp.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Eastgate Biotech Corp. (ETBI) Company Profile & Overview

EastGate Biotech Corp. is a pharmaceutical company. The Company produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body. It utilizes state-of-the-art nanotechnologies to deliver healthy alternatives to conventional pharmaceuticals that all too often create dangerous side effects and unexpected consequences for those trying to attain and maintain healthy lives. The Company’s products include E-Drops NANO, Essential D, GluCora, VCleanzz, Cleanezze and Warts X. The Company develops products in which the components are incorporated into vehicles containing nano-sized delivery vectors, including oil droplets (nanoemulsions), polymeric particles (nanoparticles) and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). It has its offices in New York, London SF, Cockfosters BP, Los Angeles, Chicago and Las Vegas.

SectorHealthcare
IndustryMedical - Pharmaceuticals
CEORosella C. Perri

Contact Information

647-692-0652
65 Harbour Square Suite 2203Toronto, M5J 2L4Canada, Toronto, NV

Company Facts

2 Employees
IPO DateMar 5, 2014
CountryUS
Actively Trading

Frequently Asked Questions

;